169 related articles for article (PubMed ID: 29340974)
1. Inhibiting 6-phosphogluconate dehydrogenase selectively targets breast cancer through AMPK activation.
Yang X; Peng X; Huang J
Clin Transl Oncol; 2018 Sep; 20(9):1145-1152. PubMed ID: 29340974
[TBL] [Abstract][Full Text] [Related]
2. Inhibiting 6-phosphogluconate dehydrogenase enhances chemotherapy efficacy in cervical cancer via AMPK-independent inhibition of RhoA and Rac1.
Guo H; Xiang Z; Zhang Y; Sun D
Clin Transl Oncol; 2019 Apr; 21(4):404-411. PubMed ID: 30182212
[TBL] [Abstract][Full Text] [Related]
3. 6PGD Upregulation is Associated with Chemo- and Immuno-Resistance of Renal Cell Carcinoma via AMPK Signaling-Dependent NADPH-Mediated Metabolic Reprograming.
Cao J; Sun X; Zhang X; Chen D
Am J Med Sci; 2020 Sep; 360(3):279-286. PubMed ID: 32829780
[TBL] [Abstract][Full Text] [Related]
4. 6PGD inhibition sensitizes hepatocellular carcinoma to chemotherapy via AMPK activation and metabolic reprogramming.
Chen H; Wu D; Bao L; Yin T; Lei D; Yu J; Tong X
Biomed Pharmacother; 2019 Mar; 111():1353-1358. PubMed ID: 30841449
[TBL] [Abstract][Full Text] [Related]
5. 6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Lin R; Elf S; Shan C; Kang HB; Ji Q; Zhou L; Hitosugi T; Zhang L; Zhang S; Seo JH; Xie J; Tucker M; Gu TL; Sudderth J; Jiang L; Mitsche M; DeBerardinis RJ; Wu S; Li Y; Mao H; Chen PR; Wang D; Chen GZ; Hurwitz SJ; Lonial S; Arellano ML; Khoury HJ; Khuri FR; Lee BH; Lei Q; Brat DJ; Ye K; Boggon TJ; He C; Kang S; Fan J; Chen J
Nat Cell Biol; 2015 Nov; 17(11):1484-96. PubMed ID: 26479318
[TBL] [Abstract][Full Text] [Related]
6. Inhibiting 6-phosphogluconate dehydrogenase reverses doxorubicin resistance in anaplastic thyroid cancer via inhibiting NADPH-dependent metabolic reprogramming.
Ma L; Cheng Q
Biochem Biophys Res Commun; 2018 Apr; 498(4):912-917. PubMed ID: 29534964
[TBL] [Abstract][Full Text] [Related]
7. Targeting 6-phosphogluconate dehydrogenase in the oxidative PPP sensitizes leukemia cells to antimalarial agent dihydroartemisinin.
Elf S; Lin R; Xia S; Pan Y; Shan C; Wu S; Lonial S; Gaddh M; Arellano ML; Khoury HJ; Khuri FR; Lee BH; Boggon TJ; Fan J; Chen J
Oncogene; 2017 Jan; 36(2):254-262. PubMed ID: 27270429
[TBL] [Abstract][Full Text] [Related]
8. Gambogic acid exhibits promising anticancer activity by inhibiting the pentose phosphate pathway in lung cancer mouse model.
Zhang Q; Zhang Y; Wang C; Tang H; Ma A; Gao P; Shi Q; Wang G; Shen S; Zhang J; Xia F; Zhu Y; Wang J
Phytomedicine; 2024 Jul; 129():155657. PubMed ID: 38692076
[TBL] [Abstract][Full Text] [Related]
9. 6-Phosphogluconate dehydrogenase regulates tumor cell migration in vitro by regulating receptor tyrosine kinase c-Met.
Chan B; VanderLaan PA; Sukhatme VP
Biochem Biophys Res Commun; 2013 Sep; 439(2):247-51. PubMed ID: 23973484
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of 6-Phosphogluconate Dehydrogenase Reverses Epirubicin Resistance Through Metabolic Reprograming in Triple-Negative Breast Cancer Cells.
Xu J; Ren G; Cheng Q
Technol Cancer Res Treat; 2023; 22():15330338231190737. PubMed ID: 37559469
[TBL] [Abstract][Full Text] [Related]
11. A feedback loop between the androgen receptor and 6-phosphogluoconate dehydrogenase (6PGD) drives prostate cancer growth.
Gillis JL; Hinneh JA; Ryan NK; Irani S; Moldovan M; Quek LE; Shrestha RK; Hanson AR; Xie J; Hoy AJ; Holst J; Centenera MM; Mills IG; Lynn DJ; Selth LA; Butler LM
Elife; 2021 Aug; 10():. PubMed ID: 34382934
[TBL] [Abstract][Full Text] [Related]
12. 6-Phosphogluconate dehydrogenase fuels multiple aspects of cancer cells: From cancer initiation to metastasis and chemoresistance.
Sarfraz I; Rasul A; Hussain G; Shah MA; Zahoor AF; Asrar M; Selamoglu Z; Ji XY; Adem Ş; Sarker SD
Biofactors; 2020 Jul; 46(4):550-562. PubMed ID: 32039535
[TBL] [Abstract][Full Text] [Related]
13. Oxidative Pentose Phosphate Pathway Enzyme 6-Phosphogluconate Dehydrogenase Plays a Key Role in Breast Cancer Metabolism.
Polat IH; Tarrado-Castellarnau M; Bharat R; Perarnau J; Benito A; Cortés R; Sabatier P; Cascante M
Biology (Basel); 2021 Jan; 10(2):. PubMed ID: 33498665
[TBL] [Abstract][Full Text] [Related]
14. Glycolytic cancer cells lacking 6-phosphogluconate dehydrogenase metabolize glucose to induce senescence.
Sukhatme VP; Chan B
FEBS Lett; 2012 Jul; 586(16):2389-95. PubMed ID: 22677172
[TBL] [Abstract][Full Text] [Related]
15. ALOX12 inhibition sensitizes breast cancer to chemotherapy via AMPK activation and inhibition of lipid synthesis.
Huang Z; Xia L; Zhou X; Wei C; Mo Q
Biochem Biophys Res Commun; 2019 Jun; 514(1):24-30. PubMed ID: 31014671
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine phosphorylation activates 6-phosphogluconate dehydrogenase and promotes tumor growth and radiation resistance.
Liu R; Li W; Tao B; Wang X; Yang Z; Zhang Y; Wang C; Liu R; Gao H; Liang J; Yang W
Nat Commun; 2019 Mar; 10(1):991. PubMed ID: 30824700
[TBL] [Abstract][Full Text] [Related]
17. Effects of nicotine and vitamin E on 6-phosphogluconate dehydrogenase activity in some rat tissues in vivo and in vitro.
Ciftci M; Yilmaz H; Coban TA; Gul M; Gumustekin K; Dane S
J Enzyme Inhib Med Chem; 2008 Apr; 23(2):261-5. PubMed ID: 18343913
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of 6-phosphogluconate Dehydrogenase Reverses Cisplatin Resistance in Ovarian and Lung Cancer.
Zheng W; Feng Q; Liu J; Guo Y; Gao L; Li R; Xu M; Yan G; Yin Z; Zhang S; Liu S; Shan C
Front Pharmacol; 2017; 8():421. PubMed ID: 28713273
[TBL] [Abstract][Full Text] [Related]
19. Lysine acetylation activates 6-phosphogluconate dehydrogenase to promote tumor growth.
Shan C; Elf S; Ji Q; Kang HB; Zhou L; Hitosugi T; Jin L; Lin R; Zhang L; Seo JH; Xie J; Tucker M; Gu TL; Sudderth J; Jiang L; DeBerardinis RJ; Wu S; Li Y; Mao H; Chen PR; Wang D; Chen GZ; Lonial S; Arellano ML; Khoury HJ; Khuri FR; Lee BH; Brat DJ; Ye K; Boggon TJ; He C; Kang S; Fan J; Chen J
Mol Cell; 2014 Aug; 55(4):552-65. PubMed ID: 25042803
[TBL] [Abstract][Full Text] [Related]
20. Critical Role of 6-Phosphogluconate Dehydrogenase in TAp73-Mediated Cancer Cell Proliferation.
Qiao R; Wei M; Chen H; Zhang X; Zhang J; Gao L; Ma H; Wang Y; Li L
Mol Cancer Res; 2023 Aug; 21(8):825-835. PubMed ID: 37071129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
